Neurological mechanisms of migraine: Potential of the gap-junction modulator tonabersat in prevention of migraine

Cephalalgia

Volumn 29, Issue SUPPL. 2, 2009, Pages 1-6

  Durham, P L ^a   Garrett, F G ^a  

^a MISSOURI STATE UNIVERSITY   (United States)

Author keywords

Connexins; Cortical spreading depression; Gap junctions; Tonabersat; Trigeminovascular

Indexed keywords

GAP JUNCTION PROTEIN; POTASSIUM CHLORIDE; SUMATRIPTAN; TONABERSAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CELL TRANSFER; CONTROLLED STUDY; DEPOLARIZATION; DISEASE COURSE; DRUG BINDING; DRUG MECHANISM; ELECTRICAL SYNAPSE; GLIA CELL; HUMAN; MIGRAINE; MIGRAINE AURA; NOCICEPTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; SENSITIZATION; SPREADING CORTICAL DEPRESSION; TRIGEMINUS GANGLION;

ANALGESICS; ANIMALS; BENZAMIDES; BENZOPYRANS; BRAIN; GAP JUNCTIONS; HUMANS; MIGRAINE DISORDERS; SPREADING CORTICAL DEPRESSION;

EID: 69549086142     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2009.01976.x     Document Type: Article

References (33)

1. Durham PL. Calcitonin gene-related peptide (CGRP) and migraine. Headache 2006 46 (Suppl. 1 S3 8.
2. Unger J. Migraine headaches: a historical perspective, a glimpse into the future, and migraine epidemiology. Dis Mon 2006 52 : 367 384.
3. Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med 2007 13 : 39 44.
4. Calabresi P, Galletti F, Rossi C, Sarchielli P, Cupini LM. Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms. Trends Pharmacol Sci 2007 28 : 188 195.
5. Dodick D, Silberstein S. Central sensitization theory of migraine: clinical implications. Headache 2006 46 (Suppl. 4 S182 91.
6. Goadsby PJ. Emerging therapies for migraine. Nature Clin Pract Neurol 2007 3 : 610 619.
7. Leao AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944 7 : 359 390.
8. Rogawski MA. Common pathophysiologic mechanisms in migraine and epilepsy. Arch Neurol 2008 65 : 709 714.
9. Netsiri C, Bradley DP, Takeda T, Smith MI, Papadakis N, Hall LD. A delayed class of BOLD waveforms associated with spreading depression in the feline cerebral cortex can be detected and characterised using independent component analysis (ICA). Magn Reson Imaging 2003 21 : 1097 1110.
10. Moskowitz MA. Pathophysiology of headache - past and present. Headache 2007 47 (Suppl. 1 S58 63.
11. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med 2002 346 : 257 270.
12. Benarroch EE. Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. Mayo Clin Proc 2005 80 : 1326 1338.
13. Stout CE, Costantin JL, Naus CCG, Charles AC. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J Biol Chem 2002 277 : 10482 10488.
14. Giaume C, McCarthy KD. Control of gap-junctional communication in astrocytic networks. Trends Neurosci 1996 19 : 319 325.
15. Laird DW. Life cycle of connexins in health and disease. Biochem J 2006 394 : 527 543.
16. Bennett MVL, Contreras JE, Bukauskas FF, Sáez JC. New roles for astrocytes: gap junction hemichannels have something to communicate. Trends Neurosci 2003 26 : 610 617.
17. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell JE. Molecular cell biology, 5th edn. New York : W. H. Freeman & Co. 2004.
18. Nagy JI, Dudek FE, Rash JE. Update on connexins and gap junctions in neurons and glia in the mammalian nervous system. Brain Res Rev 2004 47 : 191 215.
19. Chen G, Dunbar RL, Gao W, Ebner TJ. Role of calcium, glutamate neurotransmission, and nitric oxide in spreading acidification and depression in the cerebellar cortex. J Neurosci 2001 21 : 9877 9887.
20. Grafstein B, Liu S, Cotrina ML, Goldman SA, Nedergaard M. Meningeal cells can communicate with astrocytes by calcium signaling. Ann Neurol 2000 47 : 18 25.
21. Ye Z-C, Wyeth MS, Baltan-Tekkok S, Ransom BR. Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J Neurosci 2003 23 : 3588 3596.
22. Thalakoti S, Patil VV, Damodaram S, Vause CV, Langford LE, Freeman SE, Durham PL. Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache 2007 47 : 1008 1023.
23. Kielian T, Esen N. Effects of neuroinflammation on glia-glia gap junctional intercellular communication: a perspective. Neurochem Int 2004 45 : 429 436.
24. Ohara PT, Vit JP, Bhargava A, Jasmin L. Evidence for a role of connexin 43 in trigeminal pain using RNA interference in vivo. J Neurophysiol 2008 100 : 3064 3073.
25. Chan WN, Evans JM, Hadley MS, Herdon HJ, Jerman JC, Parsons AA et al. Identification of (-)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)-3,4- dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent. Bioorg Med Chem Lett 1999 9 : 285 290.
26. Upton N, Raval P, Herdon H, Jerman J, Parsons AA, Chan WN, Thompson M. SB-220453, a mechanistically novel benzopyran compound, inhibits trigeminal nerve ganglion (TGN) stimulation-induced carotid vasodilatation. Cephalalgia 1999 19 : 351.
27. MaassenVanDenBrink A, van den Broek RWM, de Vries R, Upton N, Parsons AA, Saxema PR. The potential anti-migraine compound SB-220453 does not contract human isolated blood vessels or myocardium; a comparison with sumatriptan. Cephalalgia 2000 20 : 538 545.
28. Smith MI, Read SJ, Chan WN, Thompson M, Hunter AJ, Upton N, Parsons AA. Repetitive cortical spreading depression in a gyrencephalic feline brain: inhibition by the novel benzoylamino-benzopyran SB-220453. Cephalalgia 2000 20 : 546 553.
29. Bradley DP, Smith MI, Netsiri C, Smith JM, Bockhorst KHJ, Hall LD et al. Diffusion-weighted MRI used to detect in vivo modulation of cortical spreading depression: comparison of sumatriptan and tonabersat. Exp Neurol 2001 172 : 342 353.
30. Read SJ, Smith MI, Hunter AJ, Upton N, Parsons AA. SB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat. Cephalalgia 2000 20 : 92 9.
31. Read SJ, Hirst WD, Upton N, Parsons AA. Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan. Brain Res 2001 891 : 69 77.
32. Parsons AA, Bingham S, Raval P, Read S, Thompson M, Upton N. Tonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexes. Br J Pharmacol 2001 132 : 1549 1557.
33. Durham PL, Damodaram S, Thalakoti S, Freeman SE, Garrett FG. Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling. Headache 2008 48 : S5.